Stock screener

FEMY

Conviction 62HealthcareScan · Tue, Sep 8, 2026
Bearish marubozu
FEMY$2.61-12.42%
ResistanceSupportVol 14Insider buy
63 bars
5
Vol MA14 2.91M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
FEMASYS INCSURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.femasys.com ↗
Price2.61
Change-12.42%
Gap-1.01%
Rel volume0.27×
Avg volume2.12M
Avg $ vol5.75M
SMA 202.76
SMA 503.16
SMA 2001.47
Price vs 50-17.33%
Price vs 200+77.90%
MA stackmixed
50/200 cross—
Supertrendup · 2.19
RSI (14)43
MACD hist0.02
MACD cross—
Stoch %K / %D24 / 48
ADX (14)24
+DI / −DI23 / 22
RSI divergence—
MACD divergence—
ATR %+13.44%
ADR %12.45%
52w high5.39
52w low0.3064
From 52w high-51.58%
Above 52w low+751.83%
New 52w highNo
SqueezeOff
Bollinger width53.69%
%B0.40
Donchian pos35.24%
Donchian high3.69
Donchian low2.02
AVWAP (52w high)2.91
vs AVWAP high-10.44%
AVWAP (52w low)2.78
vs AVWAP low-5.96%
OBV trendUp
Chaikin MF (20)-0.33
Today vs 20d0.27×
Avg vol (14d)2.91M
Avg vol (20d)2.12M
Avg $ vol (20d)5.75M
Market cap21.86M
RS 3m (vs SPY)+868.16%
RS 6m (vs SPY)+447.72%
RS line new highNo
Trend template6/8
Technical rank74.5
1 week-23.91%
1 month-1.88%
3 months-51.58%
6 months+399.81%
1 year+594.33%
YTD+309.93%
P/E-1.17
P/B5.42
P/S9.53
P/FCF-1.14
EPS-0.4700
Div yield—
ROE-462.12%
ROA-151.57%
Debt/Eq—
Current2.14
EV/EBITDA-1.18
Gross margin33.33%
Net margin-812.27%
Rev growth40.77%
EPS growth1.00%
Price target10.00
Target upside283.14%
Analyst ratingBuy
Institutional25.59%
Ent. value20.42M
Revenue331.83K
Net income-4.47M
Gross profit158.18K
Free cash flow-19.22M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out—
Employees54
ListedFri, Jun 18, 2021
Free float35.1M
Float %60.0%
Short interest435K
Days to cover1.6d
Short volume18.8%
Squeeze score10 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction62 / 100
Pattern quality—
Tech rank74.5 / 100
Group rank96 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish marubozu
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FEMY

All disclosures →
No recent disclosed trades by Congress in FEMY. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FEMY · 10 buys

InsiderSideShares
Canning John Charles
Chief Operating Officer · Common Stock · 2026-08-07
Buy4.38K
Canning John Charles
Chief Operating Officer · Common Stock Purchase Warrant · 2026-08-07
Grant4.38K
Canning John Charles
Chief Operating Officer · Common Stock Purchase Warrant (Milestone) · 2026-08-07
Grant4.38K
Sipos Jeremy Alexander
Chief Technology Officer · Common Stock Purchase Warrant · 2026-08-07
Grant3.13K
Sipos Jeremy Alexander
Chief Technology Officer · Common Stock Purchase Warrant (Milestone) · 2026-08-07
Grant3.13K
Mifek Jeffrey Gerald
Chief Clinical-Medical Affairs · Common Stock · 2026-08-07
Buy3.13K
Mifek Jeffrey Gerald
Chief Clinical-Medical Affairs · Common Stock Purchase Warrant · 2026-08-07
Grant3.13K
Mifek Jeffrey Gerald
Chief Clinical-Medical Affairs · Common Stock Purchase Warrant (Milestone) · 2026-08-07
Grant3.13K
Elefant Dov
Chief Financial Officer · Common Stock · 2026-08-07
Buy15.63K
Elefant Dov
Chief Financial Officer · Common Stock Purchase Warrant · 2026-08-07
Grant15.63K

SEC filings

EDGAR filings in FEMY · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.